Suppr超能文献

原发性与继发性非酒精性脂肪性肝病:关于晚期肝纤维化的观点

Primary Versus Secondary NAFLD: Perspective on Advanced Fibrosis.

作者信息

Shetty Divya, Amarapurkar Anjali, Shukla Akash

机构信息

Department of Pathology, Dr. DY Patil Medical College, Hospital and Research Centre, Nerul, Navi, Mumbai, India.

Department of Pathology, Lokmanya Tilak Municipal Medical College and Sion Hospital, Mumbai, India.

出版信息

J Clin Exp Hepatol. 2021 Sep-Oct;11(5):557-564. doi: 10.1016/j.jceh.2020.12.009. Epub 2020 Dec 31.

Abstract

BACKGROUND

The presence of macrovesicular steatosis on liver biopsy is the commonest histopathological finding. Nonalcoholic fatty liver disease (NAFLD) is the presence of ≥5% macrovesicular steatosis without significant alcohol use. It is subdivided into primary and secondary NAFLD; information on their differences is limited.

AIM

To determine the histopathological differences between primary and secondary NAFLD and establish whether the prevalence of advanced fibrosis varies between the two types.

METHODOLOGY

Three years of retrospective study of 90 liver biopsies with ≥5% macrovesicular steatosis. Age, gender, clinical history, serum transaminase levels were noted. The biopsy was reviewed for steatosis, inflammation, and fibrosis. Differences between primary and secondary NAFLD for age, gender, AST/ALT ratio, histopathological features were determined. Descriptive statistical analysis, 2-tailed Student's test, Chi-square test, Fisher's exact test were used, where p <  was considered significant.

RESULT

Primary and secondary NAFLD were 42 (46.7%) and 48 (53.3%), respectively. Inflammation was noted in 50 (55.5%) and fibrosis in 31 (34.4%). The prevalence of advanced fibrosis was 24.4%. Primary and secondary NAFLD differed significantly on ballooning degeneration, Mallory Denk bodies (MDBs), glycogenated nuclei, and fibrosis stage (p < 0.05). There were no significant differences among AST/ALT ratio, steatosis, and inflammation grade.

CONCLUSION

Primary NAFLD is a more severe type of liver disease. On histopathology, ballooning degeneration, MDBs, glycogenated nuclei, and advanced fibrosis was more prevalent in primary than secondary NAFLD.

摘要

背景

肝活检显示大泡性脂肪变性是最常见的组织病理学表现。非酒精性脂肪性肝病(NAFLD)是指存在≥5%的大泡性脂肪变性且无大量饮酒史。它可分为原发性和继发性NAFLD;关于它们之间差异的信息有限。

目的

确定原发性和继发性NAFLD的组织病理学差异,并确定两种类型中晚期纤维化的患病率是否不同。

方法

对90例大泡性脂肪变性≥5%的肝活检进行了为期三年的回顾性研究。记录年龄、性别、临床病史、血清转氨酶水平。对活检组织进行脂肪变性、炎症和纤维化评估。确定原发性和继发性NAFLD在年龄、性别、AST/ALT比值、组织病理学特征方面的差异。采用描述性统计分析、双尾学生t检验、卡方检验、费舍尔精确检验,p<0.05被认为具有统计学意义。

结果

原发性和继发性NAFLD分别为42例(46.7%)和48例(53.3%)。50例(55.5%)出现炎症,31例(34.4%)出现纤维化。晚期纤维化的患病率为24.4%。原发性和继发性NAFLD在气球样变性、马洛里小体(MDBs)、糖原核和纤维化分期方面有显著差异(p<0.05)。AST/ALT比值、脂肪变性和炎症分级之间无显著差异。

结论

原发性NAFLD是一种更严重的肝病类型。在组织病理学上,原发性NAFLD比继发性NAFLD更易出现气球样变性、MDBs、糖原核和晚期纤维化。

相似文献

1
Primary Versus Secondary NAFLD: Perspective on Advanced Fibrosis.
J Clin Exp Hepatol. 2021 Sep-Oct;11(5):557-564. doi: 10.1016/j.jceh.2020.12.009. Epub 2020 Dec 31.
4
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
6
Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies.
J Clin Exp Hepatol. 2020 May-Jun;10(3):245-254. doi: 10.1016/j.jceh.2019.07.002. Epub 2019 Jul 15.
8
Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.
Clin Gastroenterol Hepatol. 2009 Nov;7(11):1224-9, 1229.e1-2. doi: 10.1016/j.cgh.2009.06.007. Epub 2009 Jun 25.
9
Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392.
10
Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
J Med Ultrason (2001). 2020 Oct;47(4):549-554. doi: 10.1007/s10396-020-01061-3. Epub 2020 Nov 2.

引用本文的文献

1
Outcomes of fatty liver disease with and without metabolic comorbidities and risk factors for mortality.
JGH Open. 2023 May 22;7(6):410-418. doi: 10.1002/jgh3.12898. eCollection 2023 Jun.
2
Possible Development of Burn-Out Nonalcoholic Steatohepatitis under Long-Term Steroid Use.
Case Rep Gastroenterol. 2022 Sep 19;16(3):557-562. doi: 10.1159/000526570. eCollection 2022 Sep-Dec.

本文引用的文献

1
Glucocorticoid-Induced Fatty Liver Disease.
Diabetes Metab Syndr Obes. 2020 Apr 16;13:1133-1145. doi: 10.2147/DMSO.S247379. eCollection 2020.
2
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.
Gastroenterology. 2020 May;158(7):1851-1864. doi: 10.1053/j.gastro.2020.01.052. Epub 2020 Feb 13.
3
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
Gastroenterology. 2020 May;158(7):1881-1898. doi: 10.1053/j.gastro.2020.01.049. Epub 2020 Feb 8.
4
Causes of secondary non-alcoholic fatty liver disease in non-obese children below 10 years.
Eur J Pediatr. 2020 May;179(5):719-726. doi: 10.1007/s00431-019-03551-0. Epub 2020 Jan 2.
5
Fatty Liver Disease: A Practical Approach.
Arch Pathol Lab Med. 2020 Jan;144(1):62-70. doi: 10.5858/arpa.2019-0341-RA. Epub 2019 Oct 11.
9
Food-drug interaction: Anabolic steroids aggravate hepatic lipotoxicity and nonalcoholic fatty liver disease induced by trans fatty acids.
Food Chem Toxicol. 2018 Jun;116(Pt B):360-368. doi: 10.1016/j.fct.2018.04.056. Epub 2018 Apr 26.
10
Effect of hepatic steatosis on the progression of chronic hepatitis B: A prospective cohort and study.
Oncotarget. 2017 Apr 24;8(35):58601-58610. doi: 10.18632/oncotarget.17380. eCollection 2017 Aug 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验